SU 5402 Workflows for RTK Signaling Research
2026-09-08
SU 5402 enables time-resolved interrogation of VEGFR2, FGFR1, PDGFRβ, and downstream ERK1/2–STAT3 signaling, with especially useful applications in FGFR3-dependent multiple myeloma models. This guide pairs validated oncology workflows with a carefully bounded, exploratory framework for human iPSC-derived sensory-neuron studies.
Drug Response Assays: Insights from Schwartz (2022)
2026-09-08
Hannah Schwartz’s 2022 dissertation examines why relative viability and fractional viability should not be treated as interchangeable measures of anticancer drug response. Its central practical contribution is a framework for separating growth inhibition from cell killing across dose and time, improving interpretation of in vitro pharmacology experiments.
3X FLAG peptide Workflows for NLRP3 Studies
2026-09-07
The 3X (DYKDDDDK) Peptide turns FLAG-tagged expression constructs into practical tools for selective capture, immunodetection, and structural sample preparation. Applied to full-length NLRP3, it supports a workflow that preserves native oligomeric states while exposing aggregation, metal sensitivity, and tag-accessibility problems early.
CHIR-99021 (CT99021): From Wnt Control to Translation
2026-09-05
CHIR-99021 (CT99021) is more than a routine GSK-3 inhibitor: it is a strategic perturbation tool for testing how receptor-level Wnt antagonism, β-catenin stability, pluripotency, and lineage commitment interact. This thought-leadership guide connects mechanism, experimental design, product selection, and translational decision-making.
STNvac mRNA Vaccine Drives TLS Formation in HCC
2026-09-05
Lin et al. developed a spleen-targeted neoantigen mRNA vaccine, STNvac, that produced strong antitumor activity in orthotopic hepatocellular carcinoma models and was associated with improved survival. The study links this response to neoantigen-specific ISG15-positive CD8-positive T cells, GZMA-F2R signaling with antigen-presenting cells, and tertiary lymphoid structure formation.
Sphingosine-1-phosphate Assay Workflows
2026-09-04
Build receptor-aware S1P experiments for endothelial, survival, and neuronal apoptosis models. This workflow combines fresh-solution handling, concentration-response design, orthogonal readouts, and the S1PR3 findings reported after intracerebral hemorrhage.
MTT Assays as a Lens on Drug Resistance
2026-09-04
MTT transforms cellular reducing activity into a practical readout for proliferation and drug response. This evidence-focused guide explains how to interpret the assay in cisplatin-resistant ovarian cancer models without confusing metabolic signal with cell number or mechanism.
Amikacin Sulfate: From Mechanism to Translation
2026-09-03
Amikacin Sulfate is more than a conventional aminoglycoside benchmark: its translational value depends on connecting ribosomal mechanism, intracellular exposure, granuloma-directed delivery, and function-first microbiology. This article outlines a practical strategy for using Amikacin to generate more predictive non-tuberculous mycobacterial research data.
Antipyrine in BBB Permeability Research
2026-09-03
Antipyrine offers a highly soluble, high-purity test compound for linking pain and fever pharmacology with practical blood-brain barrier transport workflows. This guide shows how to use it as a carefully controlled comparator in LLC-PK1-MOCK/MDR1 assays while avoiding false conclusions caused by solvent effects, transporter activity, or lysosomal trapping.
Cinoxacin Workflows for Gram-Negative Research
2026-09-02
Cinoxacin provides a practical, mechanism-informed benchmark for urinary tract infection research, susceptibility testing, and resistance experiments involving susceptible Gram-negative organisms. This guide combines formulation guidance, assay-ready parameters, comparative interpretation, and a precision-trial framework for generating more reproducible antimicrobial data.
Cyanine 3 Tyramide in Neuroscience TSA
2026-09-02
Cyanine 3 Tyramide is an orange fluorescent dye for biomedical research that supports enzyme-mediated signal enhancement in tissue and molecular assays. Its strongest value in early-life-adversity studies is sensitive spatial visualization, while causal conclusions still require independent circuit and behavioral experiments.
Praeruptorin A: Applied Research Workflows
2026-09-01
Praeruptorin A is a multi-target angular pyranocoumarin compound for connecting ferroptosis, inflammation, epithelial-barrier, metastasis, and cardioprotection assays. This guide converts its reported dose ranges and pathway activities into practical workflows, controls, and troubleshooting decisions.
2-Thio-dCTP: A Precision Lens on Chromosome Stability
2026-09-01
Explore how 2-Thio-dCTP and 2-Thio-2'-deoxycytidine-5'-Triphosphate can sharpen DNA polymerase, site-specific modification, and DNA–protein interaction studies inspired by new SCP4 chromosome-stability findings.
BVDV Glycolytic Reprogramming and RIG-I Evasion
2026-08-31
Li et al. identify a ROS–HIF-1α–glycolysis pathway that enables bovine viral diarrhea virus (BVDV) to weaken RIG-I/MAVS signaling and increase viral replication. The study connects HK2–MAVS–VDAC1 complex formation and lactate-mediated disruption of MAVS localization to impaired type I interferon production, providing a mechanistic framework for studying viral metabolic immune evasion.
Flavopiridol Workflows for CDK and ER-Stress Studies
2026-08-30
Build more interpretable cell-cycle and apoptosis experiments with Flavopiridol, using dose-range design, orthogonal readouts, and parallel ER-stress controls. The workflow distinguishes direct CDK inhibition from tunicamycin-driven injury, helping cancer research teams translate intestinal stem-cell findings without overstating the evidence.
492 records 8/33 page Previous Next First page 上5页 678910 下5页 Last page